Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Ting Liu

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Blood|December 28, 2007
Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemiaSamir G Agrawal, Feng-Ting Liu, Catherine Wiseman, et al.
Acta Pharmacologica Sinica|October 6, 2023
Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinomaFan Yang, Lin Jia, Hong-Chao Zhou, et al.
Blood|July 1, 2011
Differential and tumor-specific expression of CD160 in B-cell malignanciesTimothy W Farren, Jerome Giustiniani, Feng-Ting Liu, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Blood|December 28, 2007
Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemiaSamir G Agrawal, Feng-Ting Liu, Catherine Wiseman, et al.
Acta Pharmacologica Sinica|October 6, 2023
Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinomaFan Yang, Lin Jia, Hong-Chao Zhou, et al.
Blood|July 1, 2011
Differential and tumor-specific expression of CD160 in B-cell malignanciesTimothy W Farren, Jerome Giustiniani, Feng-Ting Liu, et al.
Pageof 4